Roche buys MASH contender for up to US$3.5 billion - Nature

Retrieved on: 2025-10-08 16:41:45

Tags for this article:

Click the tags to see associated articles and topics

Roche buys MASH contender for up to US$3.5 billion - Nature. View article details on hiswai:

Excerpt

Roche has scooped up 89bio and its phase III FGF21 analogue pegozafermin, as drug developers continue to race to advance new drugs for the liver ...

Article found on: www.nature.com